GINETANTUM SOL VAG 5FL 140ML

GINETANTUM 0.1% VAGINAL DEPARTMENT

active ingredients

100 ml contain: Active ingredient: benzidamine hydrochloride 100 mg (equal to 89.46 mg of benzidamine). Excipient with known effect: benzalconio chloride, base pink perfume (Benzil alcohol, Benzil benzoato, Benzil cinnamato, Benzil salicylate, Citral, Citronellol, Eugenol, Farnesol, Geraniol, Limonene, Linanool). For the full list of excipients, see paragraph 6.1.

Excellent

Benzalconio chloride, edetate disode, basic pink perfume, purified water.

Therapeutic indications

Vulvovaginiti of any origin and nature, characterized by small vaginal losses, itching, irritation, burning and vulvary pain. Intimate hygiene during the boxer.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1 or to substances strictly related from the chemical point of view.

Population

Posology 1-2 vaginal irrigations per day for seven consecutive days. The solution can be used at room temperature. If you want to intiepidize it, just expose for a few minutes the bottle closed to a hot water jet.

Conservation

This medicine does not require any special condition of conservation. Store the bottle vertically.

Warnings

The use, especially if prolonged, of topical products could give rise to awareness-raising phenomena, in which case it is necessary to suspend treatment and to take appropriate therapeutic measures. Invite the patient to contact the doctor before use in case of vaginal bleeding and/or leucorrea.

Interactions

Negative interactions with other common drugs used in relevant therapy have not been observed.

Effects

Occasionally, especially with prolonged use of the product, skin irritations may occur. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions occurring after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

Overdosing

Intoxication is expected only in case of accidental ingestion of high quantities of benzidamine (>300 mg). Symptoms associated with overdose by ingestion of benzidamine are mainly of gastrointestinal nature and dependent on the central nervous system. The most frequent gastrointestinal symptoms are nausea, vomiting, abdominal pain and esophageal irritation. Symptoms to the central nervous system include dizziness, hallucinations, agitation, anxiety and irritability. In case of acute overdose, only symptomatic treatment can be performed. Patients should be kept under close observation, and should receive support treatment. An adequate hydration must be maintained.

There are no contraindications to the topical use of benzidamine during pregnancy or breastfeeding.

Source: Farmadati